Bio Essence (BIOE) Liabilities and Shareholders Equity (2020 - 2026)

Bio Essence's Liabilities and Shareholders Equity history runs 7 years deep, the most recent figure standing at $789032.0 for Q1 2026.

• In Q1 2026, Liabilities and Shareholders Equity rose 115.75% year-over-year to $789032.0; the TTM figure through Mar 2026 stood at $1.5 million (down 56.38% YoY), while the FY2025 annual figure was $422474.0, up 50.33% from the prior year.
• Liabilities and Shareholders Equity was $789032.0 for Q1 2026 at Bio Essence, up from $422474.0 in the prior quarter.
• In the past five years, Liabilities and Shareholders Equity ranged from a high of $2.8 million in Q4 2023 to a low of $112692.0 in Q2 2025.
• Historically, Liabilities and Shareholders Equity has averaged $1.3 million across 5 years, with a median of $1.5 million in 2023.
• The sharpest annual moves came in 2025 and 2026: Liabilities and Shareholders Equity sank 94.62% in 2025, then soared 115.75% in 2026.
• A 5-year view of Liabilities and Shareholders Equity shows it stood at $1.5 million in 2022, then soared by 78.23% to $2.8 million in 2023, then slumped by 89.81% to $281024.0 in 2024, then jumped by 50.33% to $422474.0 in 2025, then soared by 86.76% to $789032.0 in 2026.
• The last three Liabilities and Shareholders Equity figures came in at $789032.0 (Q1 2026), $422474.0 (Q4 2025), and $184534.0 (Q3 2025), per Business Quant data.